Literature DB >> 27614334

Device Survival after Primary Implantation of an Artificial Urinary Sphincter for Male Stress Urinary Incontinence.

Faysal A Yafi1, Kenneth J DeLay1, Carrie Stewart1, Jason Chiang1, Premsant Sangkum2, Wayne J G Hellstrom3.   

Abstract

PURPOSE: The AMS 800™ artificial urinary sphincter remains the gold standard for the surgical management of male stress urinary incontinence. We reviewed artificial urinary sphincter device survival after primary implantation.
MATERIALS AND METHODS: Retrospective data were collected from the AMS 800 patient information form database. Since 1972, 77,512 patient information forms for primary artificial urinary sphincter implantation have been completed in the United States. Following exclusion of procedures performed in children and females, and those labeled with an unknown surgical technique, 27,096 artificial urinary sphincter cases were included in the analysis. Collected variables included patient age, surgical approach, number of cuffs and surgeon volume. Measured outcomes included device explantation, device revision, component revision and time to each event.
RESULTS: Artificial urinary sphincter insertion was performed by low volume implanters in 22,165 (82.6%) cases. The approach was perineal in 18,373 cases (67.8%) and a tandem cuff was used in 2,224 cases (8.2%). Overall 5,723 cases required revision or explantation (21.1%). Younger age and penoscrotal approach were associated with higher device explantation and revision rates, while the use of a tandem cuff was associated with higher explantation rates. On multivariate analysis younger age, penoscrotal approach and use of a tandem cuff but not surgeon volume were significant factors associated with device explantation and component revision.
CONCLUSIONS: These data provide a general overview of artificial urinary sphincter device survival and may serve urologists when counseling patients. Younger age, penoscrotal approach and use of a tandem cuff may be associated with inferior outcomes.
Copyright © 2017 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  artificial; device removal; reoperation; urinary incontinence; urinary sphincter

Mesh:

Year:  2016        PMID: 27614334     DOI: 10.1016/j.juro.2016.08.107

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

Review 1.  Artificial Urinary Sphincter Complications: Risk Factors, Workup, and Clinical Approach.

Authors:  Roger K Khouri; Nicolas M Ortiz; Benjamin M Dropkin; Gregory A Joice; Adam S Baumgarten; Allen F Morey; Steven J Hudak
Journal:  Curr Urol Rep       Date:  2021-03-29       Impact factor: 3.092

Review 2.  Penoscrotal Incision for the Primary Implantation of an Artificial Urinary Sphincter.

Authors:  Caroline Jamaer; Helene De Bruyn; Alexander Van Renterghem; Evert Baten; Koenraad Van Renterghem
Journal:  Curr Urol       Date:  2020-06-23

3.  Artificial sphincter "BR - SL - AS 904" in the treatment of urinary incontinence after radical prostatectomy: efficacy, practicality and safety in a prospective and multicenter study.

Authors:  Salvador Vilar Correia Lima; Evandilson Guenes Campos de Barros; Fabio de Oliveira Vilar; Flavia Cristina Morone Pinto; Thomé Décio Pinheiro Barros; José Carlos Truzzi; Luiz Gustavo M de Toledo; Francisco Kanasiro; João Luiz Amaro
Journal:  Int Braz J Urol       Date:  2018 Nov-Dec       Impact factor: 1.541

4.  Artificial Urinary Sphincter Cuff Size Predicts Outcome in Male Patients Treated for Stress Incontinence: Results of a Large Central European Multicenter Cohort Study.

Authors:  Fabian Queissert; Tanja Huesch; Alexander Kretschmer; Ralf Anding; Martin Kurosch; Ruth Kirschner-Hermanns; Tobias Pottek; Roberto Olianas; Alexander Friedl; Jesco Pfitzenmaier; Carsten M Naumann; Carola Wotzka; Joanne Nyarangi-Dix; Torben Hoffmann; Edwin Herrmann; Alice Obaje; Achim Rose; Roland Homberg; Rudi Abdunnur; Hagen Loertzer; Ricarda M Bauer; Axel Haferkamp; Andres J Schrader
Journal:  Int Neurourol J       Date:  2019-09-30       Impact factor: 2.835

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.